NCT03333096 is a NA clinical trial of Ocusweep test battery in Glaucoma, sponsored by Turku University Hospital.

Who is sponsoring NCT03333096?

NCT03333096 is sponsored by Turku University Hospital.

What drugs are being tested in NCT03333096?

Interventions in NCT03333096: Ocusweep test battery, Neuropsychological test battery.

What condition does NCT03333096 study?

NCT03333096 studies Glaucoma, Mild Cognitive Impairment, Glaucoma and Mild Cognitive Impairment, Healthy.

Is NCT03333096 still recruiting?

NCT03333096 is currently status unknown. Last updated 19 February 2018.

Last reviewed 2018-02-19 · How we verify

NCT03333096

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing Neurovisual Function in Patients With Cognitive Impairment

Status unknown NA Last updated 19 February 2018

What this trial tests

NA trial testing Ocusweep test battery in Glaucoma in 60 participants. Status unknown.

Timeline

1 December 2017

Primary endpoint
1 January 2019

1 January 2019

Quick facts

Lead sponsor	Turku University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	60
Start date	1 December 2017
Primary completion	1 January 2019
Estimated completion	1 January 2019
Sites	1 location across Finland

Drugs / interventions tested

Ocusweep test battery
Neuropsychological test battery

Conditions studied

Glaucoma — all drugs for Glaucoma →
Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
Glaucoma and Mild Cognitive Impairment — all drugs for Glaucoma and Mild Cognitive Impairment →
Healthy — all drugs for Healthy →

Sponsor

Turku University Hospital

Who can join

65 and older, any sex, with Glaucoma or Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to measure fitness to drive in patients with a visual and a cognitive impairment. To do so, Ocusweep is used in patients with glaucoma and Mild Cognitive Impairment. The participants will be divided over four groups; patients with glaucoma, patients with cognitive impairment, patients with both and a healthy control group. Differences in performance on Ocusweep in the four different groups of participants are expected. These effects may be related to fitness to drive, which is why those results will be compared to traditional neuropsychological measures of fitness to drive. the hypothesis of the current study is that the Ocusweep performance is related to performance on other measures of fitness to drive.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Cognitive Dysfunctions in Glaucoma: An Overview of Morpho-Functional Mechanisms and the Impact on Higher-Order Visual Function.
Arrigo A, Aragona E, Saladino A, Arrigo D, et al · · 2021 · cited 11× · PMID 34690746 · DOI 10.3389/fnagi.2021.747050

Verify or expand the search:

Other recruiting trials for Glaucoma

Currently open trials in the same condition.

NCT07455786 — Modified Trabeculectomy After Failure of Combined Phaco With GATT · NA · recruiting
NCT07298356 — Automated Applanation Tonometry - Updated · NA · recruiting
NCT07217678 — Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use · Phase 4 · recruiting
NCT07145073 — Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies · NA · recruiting
NCT07209410 — Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanopro · Phase 4 · recruiting

Other Turku University Hospital trials

Trials by the same sponsor.

NCT07488494 — Effective Implementation of the Physical Activity and Motor Skills Intervention for 3-6-year-old Children With Cancer (E · NA · not yet recruiting
NCT07316868 — Neuroprotective Effect of Mild Hypothermia Versus Normothermia During Cardiopulmonary Bypass of Coronary Artery Surgery · NA · not yet recruiting
NCT07306000 — Pilot Study: Effects of CCP Intervention on NICU Environment and Preterm Infants Development · NA · recruiting
NCT07272824 — Usability Study of Gestational and Postpartum Weight Management Program · recruiting
NCT07310472 — Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03333096 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Turku University Hospital
Last refreshed: 19 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03333096.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing